Literature DB >> 7752581

Puromycin aminonucleoside inhibits mesangial cell-induced contraction of collagen gels by stimulating production of reactive oxygen species.

R Zent1, M Ailenberg, T K Waddell, G P Downey, M Silverman.   

Abstract

Glomerular epithelial cell injury is thought to be the primary reason for the development of proteinuria in puromycin aminonucleoside nephrosis (PAN), the rat model of nephrotic syndrome. By comparison mesangial cells are considered resistant to the effects of puromycin. The purpose of the present study was to investigate whether puromycin in non cytotoxic concentrations caused mesangial cell dysfunction, with particular reference to cell-extracellular matrix interactions. Mesangial cells, when embedded in collagen gels, contact after exposure to minimal essential medium (MEM) containing fetal bovine serum (FBS). This contractility, measured by determining changes in area of the collagen gel, is inhibited by puromycin in a dose dependent manner from 2.5 micrograms/ml to 160 micrograms/ml. At these concentrations there is no alteration of cell viability as measured by the tetrazolium salt (MTT) method and trypan blue exclusion. Immunocytochemistry with rhodamine phalloidin reveals that actin filaments are not disrupted. The antioxidants, superoxide dismutase (SOD) and catalase as well as diphenylene iodonium (DPI), a flavoprotein inhibitor, not only counteracted the effect of puromycin on gel contraction, but also enhanced gel contraction when added to mesangial cells on their own. Aminotriazole, an inhibitor of endogenous catalase, inhibited mesangial cell-induced gel contraction in a dose dependent manner (5 mM to 40 mM), and this effect was completely reversed by addition of catalase. Mesangial cells preloaded with dihydrorhodamine and exposed to puromycin (5 micrograms/ml to 160 micrograms/ml) exhibited a dose dependent increase in rhodamine 123 fluorescence, indicating production of reactive oxygen species (ROS). This effect was blocked by the addition of DPI.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752581     DOI: 10.1038/ki.1995.123

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Inhibition of human lymphocyte function by organic solvents.

Authors:  A S Shoker; M A Murabit; F F Georges; L F Qualtiere; H G Deneer; K Prasad
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

2.  Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.

Authors:  Magaly Martinez-Ferrer; Ali-Reza Afshar-Sherif; Consolate Uwamariya; Benoit de Crombrugghe; Jeffrey M Davidson; Neil A Bhowmick
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

3.  Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

Authors:  Tetyana L Vasylyeva; Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-03-23       Impact factor: 2.372

4.  Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity.

Authors:  Joan M Cook-Mills; Jacob D Johnson; Tracy L Deem; Atsuo Ochi; Lei Wang; Yi Zheng
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

5.  Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury.

Authors:  Xiwu Chen; Gilbert Moeckel; Jason D Morrow; Dominic Cosgrove; Raymond C Harris; Agnes B Fogo; Roy Zent; Ambra Pozzi
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.